Beauty is in the Eye

It has been said that eyes are the gateway to the soul. They are also the center of the face, and can communicate to others how we think and feel.
As we age, loose skin and dark circles under the eyes can make us look tired and fatigued. Fortunately, these issues can be addressed with safe and relatively painless procedures performed by a trained professional. Let us take this opportunity to introduce you to the newest member of our team!
Jane S. Kim, MD is a board-certified and fellowship-trained oculofacial surgeon who specializes in surgical and non-surgical procedures around the eyes, brows, forehead, and mid-face. She has special interests in cosmetic and reconstructive surgery, revision eyelid surgery, and Asian blepharoplasty.
“The key to looking refreshed and rested is choosing the right option for the right patient, whether that is skin care, injectables, surgery, or some combination thereof.”
Dr. Kim is committed to patient care. Her expertise lies in both functional and cosmetic surgery of the upper and mid-face, with special attention to the region around the eyes. She also specializes in non-surgical facial rejuvenation, including dermal fillers, neurotoxin injections, laser resurfacing, and chemical peels.
DR. KIM SPECIALIZES IN:
- Upper & Lower Eyelid Surgery (Blepharoplasty)
- Revision Eyelid Surgery
- Brow & Forehead Lift
- Asian Blepharoplasty
- Orbital & Periorbital Rehabilitation for Thyroid Eye Disease
- Ptosis Repair
- Skin Cancer/Mohs Reconstruction
- Injectable Treatments (Botox & Fillers)
- Laser Resurfacing
- Chemical Peels

Before and After Images of some patients who have come Dr. Kim improve their eyes. If you are interested in meeting with Dr. Kim, please call our office to schedule an appointment.
Dr. Kim’s CONSULTATION FEE will be waived through March 31, 2025. |